ANDOVER, Massachusetts and
LONDON, August 28, 2015 /PRNewswire/ --
Insights-driven approach seamlessly
connects people, technologies and care protocols across the
health continuum improving outcomes and the cost of
healthcare delivery
Royal Philips (NYSE: PHG AEX: PHIA) today announced
its presence at ESC Congress 2015, where the company is
showcasing its latest cardiology solutions, including Heart
ModelA.I., EchoNavigator and IntelliSpace
Cardiovascular, that connect people and technology with care
protocols to assist diagnosis, guide treatment and enable home
care.
(Photo:
http://photos.prnewswire.com/prnh/20150824/260655 )
(Photo:
http://photos.prnewswire.com/prnh/20150824/260656 )
(Photo:
http://photos.prnewswire.com/prnh/20150824/260657 )
Visitors to the Philips booth (#G200) will experience
Philips' holistic approach to cardiovascular care, featuring its
best in class digital tools and capabilities for image guided
therapy and ultrasound, intravascular imaging and sensing,
treatment, patient monitoring, healthcare IT and advanced software
applications driving advancements in predictive and precision
medicine in cardiovascular care.
"Holistic cardiovascular care looks beyond the disease to
understand what really matters for all involved along the patient
journey," said Bert van Meurs, General Manager, Image Guided
Therapy for Philips. "Our patient-centric solutions enable novel
and effective minimally invasive procedures to diagnose and treat
cardiovascular disease. These solutions also support physicians
when assessing disease states, help decide and guide the right
treatment and confirm whether interventions were successful. In
addition, our recent acquisition of Volcano will increase our
capabilities to deliver this support to both physicians and
patients."
ESC Congress 2015 is the largest and most influential cardiology
event in the world, and will showcase the industry's most promising
research and leading innovations. Throughout the event, Philips and
their physician partners will participate in several Satellite
Symposia and hands-on tutorials on topics including anatomical
intelligence and peri-interventional imaging, discussing the latest
advances in diagnostic and interventional echo.
Philips' newest ultrasound technology cardiac tool,
HeartModelA.I., which
brings automated 3D views, robust reproducibility and advanced
quantification to cardiac ultrasound imaging, will make its
European debut at the Philips Booth (#G200). Philips will also
offer demonstrations at the booth of its advanced imaging and
ultrasound solutions designed for every step of the patient
journey, including:
Delivering More Confident Decision-Making
- HeartModel - part of a suite of new tools and technologies
available on Philips' EPIQ Ultrasound system designed to enhance
automation and reproducibility, and helps to address some of the
most critical strains on overburdened hospitals and healthcare
systems challenged to provide higher quality care at lower
costs
- IntelliSpace Cardiovascular - this workspace gives access to
the full range of images and includes a cardiac history timeline to
provide a comprehensive overview of the patients' care along the
health continuum
- Minicare 1-20 Acute* - A user-friendly handheld point-of-care
blood testing platform that speeds up clinical diagnosis by
providing results within minutes
Guiding the Optimal Treatment Path
- EchoNavigator - Fuses live 3D TEE and X-ray in real time to
provide image guidance in the 3D space, supporting physicians in
complex structural heart procedures to decide, guide and confirm
the optimal treatment path, enabling better patient outcomes and
more cost effective care
- AlluraClarity - simplifies procedures and improves workflow,
while delivering excellent image quality at a lower dose
- Volcano IVUS (intravascular ultrasound) - provides detailed and
accurate measurements of the vessel and over a wide range of
clinical studies has been shown to help ensure accurate stent
expansion and apposition and a reduced need for x-ray imaging
- Volcano iFR Scout™ - pullback technology that reveals the
physiologic profile of the entire vessel and is optimized to assess
serial lesions and diffuse coronary disease enabling physicians to
make informed treatment decisions
For more information on Philips presence at ESC Congress 2015,
please visit http://www.philips.com/esc and follow #ESCCongress
conversation @PhilipsLiveFrom to continue the conversation.
*Minicare is still under development and not yet available for
sale
About Royal
Philips
Royal Philips (NYSE: PHG, AEX:
PHIA) is a diversified health and well-being company, focused on
improving people's lives through meaningful innovation in the areas
of Healthcare, Consumer Lifestyle and Lighting. Headquartered in
the Netherlands, Philips posted
2014 sales of EUR 21.4 billion and
employs approximately 108,000 employees with sales and services in
more than 100 countries. The company is a leader in cardiac care,
acute care and home healthcare, energy efficient lighting solutions
and new lighting applications, as well as male shaving and grooming
and oral healthcare. News from Philips is located at
http://www.philips.com/newscenter.
For more information, please
contact:
Kathy O'Reilly
Philips Group Communications
Tel: +1-978-659-2638 Mobile: +1-978-221-8919
Email: Kathy.oreilly@philips.com
Twitter: @kathyoreilly
SOURCE Royal Philips